Gain Therapeutics, Inc. Common Stock (GANX)

$1.69 +3.05%

EARNINGS ANALYTICS

event_upcoming Est. Next Earnings: 2026-08-10 ESTIMATED

Since Nov 12, 2021, Gain Therapeutics, Inc. Common Stock (GANX) has reported earnings 19 times. On average the shares move ±3.00% post-earnings, with a positive reaction 52.6% of the time. Its largest post-earnings gain was +8.46% (Nov 12, 2021) and its largest decline was -8.09% (Mar 27, 2025). The next earnings report is predicted for 2026-08-10 (estimated).

Earnings Price Reaction

Scroll to zoom, drag to pan — click earnings dots for details

Beat Miss

Earnings Impact

Total Earnings

Avg Abs. Movement

±3.00%

Positive %

52.6%

Negative %

47.4%

Historical Earnings Statistics

Date	Timing	Open	High	Close	Volume	Movement %	SEC Filing
May 11, 2026	☽ POST	$1.81	$1.83	$1.83	24,560	-1.09%	open_in_new
Mar 26, 2026	☽ POST	$1.97	$2.06	$1.89	26,756	-3.7%	open_in_new
Nov 12, 2025	☽ POST	$2.94	$3.02	$2.96	87,178	+0.85%	open_in_new
Aug 12, 2025	☽ POST	$1.50	$1.54	$1.54	3,239	+1.95%	open_in_new
May 14, 2025	☽ POST	$1.93	$1.93	$1.87	12,930	-3.74%	open_in_new
Mar 27, 2025	☽ POST	$2.03	$2.06	$2.04	2,816	-8.09%	open_in_new
Nov 14, 2024	☽ POST	$1.96	$1.96	$1.75	8,679	+7.16%	open_in_new
Aug 08, 2024	☽ POST	$0.94	$0.99	$0.96	5,510	+2.06%	open_in_new
May 14, 2024	☽ POST	$2.43	$2.49	$2.36	2,110	+5.51%	open_in_new
Mar 26, 2024	☽ POST	$3.67	$3.95	$3.83	1,508	-3.01%	open_in_new
Nov 14, 2023	☽ POST	$2.73	$2.73	$2.73	0	+0%	open_in_new
Aug 10, 2023	☽ POST	$3.56	$3.68	$3.56	1,367	-0.56%	open_in_new
May 12, 2023	☀ PRE	$5.24	$5.26	$5.10	2,222	-0.97%	open_in_new
Mar 23, 2023	☽ POST	$4.93	$4.93	$4.83	1,000	-0.62%	open_in_new
Nov 10, 2022	☽ POST	$3.09	$3.09	$3.09	100	+0%	open_in_new
Aug 08, 2022	☀ PRE	$4.14	$4.14	$4.14	210	+4.55%	open_in_new
May 16, 2022	☽ POST	$2.68	$2.68	$2.67	700	-1.87%	open_in_new
Mar 24, 2022	☀ PRE	$4.53	$4.53	$4.53	148	+2.72%	open_in_new
Nov 12, 2021	☀ PRE	$7.57	$8.40	$8.08	2,440	+8.46%	open_in_new

event

Earnings Count

Total earnings in dataset

trending_up

Avg Abs. Movement

±3.00%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

SEC Filing Types

description 8-K

1 chevron_right

Recent SEC Filings

1 most recent

Form	Date Filed	View on EDGAR
8-K	20260526	open_in_new SEC.gov

Frequently asked about GANX earnings

When does Gain Therapeutics, Inc. Common Stock report earnings next? expand_more

Gain Therapeutics, Inc. Common Stock (GANX)'s next earnings date is estimated for 2026-08-10. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does GANX stock move after earnings? expand_more

Over 19 reports, GANX has moved an average of ±3.00% the session after earnings, closing higher 52.6% of the time.

What was GANX's biggest post-earnings move? expand_more

GANX's largest post-earnings gain on record was +8.46% on Nov 12, 2021, and its largest decline was -8.09% on Mar 27, 2025.

Where can I find Gain Therapeutics, Inc. Common Stock's SEC filings? expand_more

All of Gain Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.